Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Alidousty

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
BMC Cancer|May 14, 2020
Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitorsSvenja Wagener-Ryczek, Carina Heydt, Juliane Süptitz, et al.
Gene|November 19, 2023
Frequency and functional characterization of fusion genes in squamous cell carcinoma of the lungChristina Alidousty, Arvid Becker, Elke Binot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2018
YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathyLydia Gibbert, Daniela Hermert, Jialin Wang, et al.
Histopathology|September 18, 2020
Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lungChristina Alidousty, Nicolai Duerbaum, Svenja Wagener-Ryczek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
YB-1 is an early and central mediator of bacterial and sterile inflammation in vivoLydia Hanssen, Christina Alidousty, Sonja Djudjaj, et al.
The Journal of Pathology|June 10, 2018
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutationsChristina Alidousty, Till Baar, Luciano G Martelotto, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2023
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerFabinshy Thangarajah, Jana Busshoff, Janina Salamon, et al.
Clinical and Translational Medicine|June 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic markerPatrick S Plum, Timo Hess, Denis Bertrand, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BMC Cancer|May 14, 2020
Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitorsSvenja Wagener-Ryczek, Carina Heydt, Juliane Süptitz, et al.
Gene|November 19, 2023
Frequency and functional characterization of fusion genes in squamous cell carcinoma of the lungChristina Alidousty, Arvid Becker, Elke Binot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2018
YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathyLydia Gibbert, Daniela Hermert, Jialin Wang, et al.
Histopathology|September 18, 2020
Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lungChristina Alidousty, Nicolai Duerbaum, Svenja Wagener-Ryczek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
YB-1 is an early and central mediator of bacterial and sterile inflammation in vivoLydia Hanssen, Christina Alidousty, Sonja Djudjaj, et al.
The Journal of Pathology|June 10, 2018
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutationsChristina Alidousty, Till Baar, Luciano G Martelotto, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2023
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerFabinshy Thangarajah, Jana Busshoff, Janina Salamon, et al.
Clinical and Translational Medicine|June 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic markerPatrick S Plum, Timo Hess, Denis Bertrand, et al.
Pageof 2